This is a project more comprehensively determine the genetic factors associated with PSA levels, and to develop and apply prediction models for PCa outcomes based on genetically-adjusted PSA levels throughout life, by executing the following specific aims. This will be a multi-site and Multiple PI study that seeks to assess these questions in the GERA, PCPT, USC, UCSF and other cohorts.
Precision Prostate Cancer Screening with Genetically Adjusted Prostate-Specific Antigen Levels
Investigator: Van Den Eeden, Stephen
Funder: National Institute of Diabetes and Digestive and Kidney Diseases
